The MedTech Strategist puts Salvia BioElectronics in the spotlight

The March 13, 2019 (Vol. 6, No. 4) issue of MedTech Strategist, the main specialist journal covering the global medical device industry, devoted an article on Salvia BioElectronics: “Salvia BioElectronics: a neurostimulation platform for migraine.” The MedTech Strategist listed Salvia as ‘startup-to-watch’ in this 2-page interview with Salvia’s CEO Hubert Martens, who explains the indication that Salvia addresses and the company’s ambition to provide an effective drug-free solution for chronic migraine that is as easy as taking meds.

The original article can be found here.